DOI QR코드

DOI QR Code

2-Nonadecanone Alleviates Depression through Inflammation Relief in SD Rat

  • Lee, Gil-Hyun (Department of Clinical Laboratory Science, Kyungwon University) ;
  • Hyun, Kyung-Yae (Department of Clinical Laboratory Science, Dong-Eui University)
  • 투고 : 2018.07.26
  • 심사 : 2018.08.31
  • 발행 : 2018.09.30

초록

Depression is a type of mood disorder characterized by hypochondriasis, decreased appetite, and insomnia. Depression is a disease that affects more than 100 million people worldwide. 2-Nonadecanone (NAC) is a bioactive substance that constitutes Fomes fomentarius, and NAC is expected to have an antidepressant effect. By using the forced swimming test (FST), we investigated the effects of treatment with NAC on immobility subacutely in rats after oral dosing once a day for 2 days. Serum levels of cytokine interleukin-1 beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) were determined by enzyme-linked immunosorbent assay (ELISA). Nuclear factor-2 (Nrf-2) and inducible nitric oxide synthases (iNOS) were analyzed by western blot method. NAC dose-dependently decreased immobility in the FST. NAC dosedependently decreased FST-induced increase of cytokine levels, as manifested by significantly stronger effects on $IL-1{\beta}$ and $TNF-{\alpha}$ levels at higher doses than the lowest dose of NAC. Western blot analysis showed that Nrf-2 was significantly lower in the NAC-treated group than in the disease-induced group. The iNOS results were also significantly lower in the NAC-treated group than in the other groups. Considering FST results, the antidepressant effect of NAC is effective. Considering the results of cytokine and protein expression, this anti-depressant effect may be related to the anti-inflammatory effect. Therefore, it can be said that the anti-inflammatory effect of NAC increases the antidepressant effect in the FST experiment.

키워드

참고문헌

  1. Agarwal P, Pan X, Sambamoorthi U. Depression treatment patterns among individuals with osteoarthritis: a cross sectional study. BMC Psychiatry. 2013. 22: 111-121.
  2. Anne GB, Wendy J, Donald WH, Natasha ML. Upward counterfactual thinking and depression: A meta-analysis. Clinical Psychology. 2017. 55: 56-73.
  3. Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav. 2013. 13: 227-239.
  4. Casey DA. Depression in Older Adults: A Treatable Medical Condition. Prim Care. 2017. 44: 499-510. https://doi.org/10.1016/j.pop.2017.04.007
  5. Corn JE, Vucic D. Ubiquitin in inflammation: the right linkage makes all the difference. Nat Struct Mol Biol. 2014. 21: 297 -300. https://doi.org/10.1038/nsmb.2808
  6. Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev. 2005. 29: 547-569. https://doi.org/10.1016/j.neubiorev.2005.03.008
  7. Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behavioural Brain Research. 1996. 73: 43-46.
  8. Grande I, Magalhaes PV, Kunz M, Vieta E, Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav. 2012. 106: 46-50. https://doi.org/10.1016/j.physbeh.2011.10.029
  9. Maglanoc LA, Landro NI, Jonassen R, Kaufmann T, Cordova-Palomera A, Hilland E, Westlye LT. Data-Driven Clustering Reveals a Link Between Symptoms and Functional Brain Connectivity in Depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. 6: 21-30.
  10. McGeer PL, Rogers J, McGeer EG. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis. 2006. 9: 271-276. https://doi.org/10.3233/JAD-2006-9S330
  11. Omar NN, Tash RF. Fluoxetine coupled with zinc in a chronic mild stress model of depression: Providing a reservoir for optimum zinc signaling and neuronal remodeling. Pharmacol Biochem Behav. 2017. 160: 30-38. https://doi.org/10.1016/j.pbb.2017.08.003
  12. Peila R, Launer LJ. Inflammation and dementia: epidemiologic evidence. Acta Neurol Scand Suppl. 2006. 185: 102-106.
  13. Quagliato LA, Nardi AE. Cytokine alterations in panic disorder: A systematic review. J Affect Disord. 2018. 1: 91-96.
  14. Schreck CB. Stress and fish reproduction: the roles of allostasis and hormesis. Gen Comp Endocrinol. 2010. 165: 549-556. https://doi.org/10.1016/j.ygcen.2009.07.004
  15. Tan W, Yu KQ, Liu YY, Ouyang MZ, Yan MH, Luo R, Zhao XS. Anti-fatigue activity of polysaccharides extract from Radix Rehmanniae Preparata. Int J Biol Macromol. 2012. 50: 59-62. https://doi.org/10.1016/j.ijbiomac.2011.09.019
  16. Yan HC, Cao X, Das M, Zhu XH, Gao TM. Behavioral animal models of depression. Neurosci Bull. 2010. 26: 327-337. https://doi.org/10.1007/s12264-010-0323-7
  17. Zhang. Chemical compositions and antiproliferation activities of the chloroform fraction from Pyropolyporus fomentarius in K562 cells. Hum Exp Toxicol. 2015. 34: 732-743. https://doi.org/10.1177/0960327114558888
  18. Zhou XY, Zhang F, Ying CJ, Chen J, Chen L, Dong J, Shi Y, Tang M, Hu XT, Pan ZH, Xu NN, Zheng KY, Tang RX, Song YJ. Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway. Behav Brain Res. 2017. 30: 70-82.